Multitissular Effect of Vertical Mobilization Using the Exoskeleton AtalanteTM in Neurological Chair- or Bed-bound Patients
NCT ID: NCT05506306
Last Updated: 2022-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2022-09-01
2024-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: Observational cohort study. Inclusion criteria: bed- or wheelchair-bound for \>2 weeks and \<1 hour per day of stance, due to a central neurological disorder. Sessions with exoskeleton were 3/week, integrated in routine care. Data collected at baseline and after eight weeks (W8) included: cardiovascular (echocardiography, EKG, blood pressure lying and standing), pulmonary (spirometry), bone (densitometry, biochemical markers), bowels (daily stool frequency, Bristol Stool Scale), urinary (urinary flow, postmictional residual volume, urinary symptom profile questionnaire, USP), cognitive (trail making test, TMT-B), anxiety and depression (HAD), and quality of life (SF12).
Results will be presented at the end of the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Atalante Exoskeleton in the Rehabilitation of Patients With Amyotrophic Lateral Sclerosis
NCT06199284
Effect of the Atalante Exoskeleton on Standing and Walking in Individuals With Paraplegia: A Prospective Controlled-Environment Study in a Rehabilitation Context
NCT06941896
Evaluation of Safety and Performance of the Atalante System With Patients With Lower Limb Paralysis
NCT04110561
Lower-Limb Exoskeleton Technology for Non-Ambulatory Individuals With Spinal Cord Injury
NCT07128901
Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia
NCT06939634
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment
Clinical, biological and imagery before and after 6 weeks of using AtalanteTM exoskeleton
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* neuroligical lesion
* chair or bed bound more than 23h/24h and more than 2 weeks
* over 18 years old
Exclusion Criteria
* any porotic fracture
* heel pressure sore
* Height \> 150 cms, \> 190 cms
* Weight \< 30 kgs \> 90 kgs
* recent thoracic or abdominal surgery
* pregnancy
* range of motion aloud to use the exoskeleton
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henri Mondor University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ETIENNE SAVARD
hospital practicioner
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A0134142
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.